Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 116770
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.116770
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.116770
Table 2 Comparison of differences in liver magnetic resonance imaging parameters among patients with different efficacy groups of liver cancer interventional therapy, mean ± SD
| Group | Number of cases | Apparent diffusion coefficient difference | Transport constant difference (minute-1) | Rate constant difference | Volume fraction difference | Tumor volume difference (cm3) |
| Effective group | 71 | 0.34 ± 0.08 | 0.24 ± 0.06 | 0.47 ± 0.12 | 0.46 ± 0.13 | 10.57 ± 2.34 |
| Ineffective group | 49 | 0.14 ± 0.03 | 0.13 ± 0.02 | 0.18 ± 0.04 | 0.19 ± 0.05 | 2.86 ± 0.45 |
| t value | 17.525 | 12.355 | 16.285 | 13.835 | 22.747 | |
| P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Huang YH, Liu XL, Yang Z. Evaluating the efficacy of interventional hepatocellular carcinoma via dynamic contrast-enhanced magnetic resonance imaging: A retrospective study. World J Gastrointest Oncol 2026; 18(6): 116770
- URL: https://www.wjgnet.com/1948-5204/full/v18/i6/116770.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i6.116770